$1.52
0.021.33%
In chiusura: -
$1.51
-0.00730-0.48%
After hour: Oct 3, 5:04 PM EDT
Comments
Loading...
Attività di insider trading
Tieni traccia delle ultime attività di insider trading Pliant Therapeutics. Rimani informato sui recenti acquisti, vendite e impatto sul mercato per le azioni Pliant Therapeutics.
Cos'è l'attività interna?
L'attività di insider trading coinvolge soggetti interni all'azienda, come dirigenti, direttori e dipendenti, impegnati in transazioni sulle azioni della propria azienda. Le transazioni di acquisto e vendita degli addetti ai lavori forniscono informazioni preziose sulla loro fiducia nelle prestazioni future dell'azienda.
Cosa stanno facendo gli Pliant Therapeutics Inc addetti ai lavori?
Gli addetti ai lavori non hanno segnalato acquisti/vendite negli ultimi 30 giorni.
Notevoli acquisti e vendite recenti di insider
Non ci sono stati acquisti o vendite da parte di Insider negli ultimi 90 giorni.
Statistiche sulla proprietà per Pliant Therapeutics Inc
Numero di azioni emesse
61.388M
Azioni possedute dagli insider
1.723M
Percentuale posseduta dagli Insider
2.81%
Azioni possedute dagli investitori istituzionali
6.532M
Percentuale posseduta dagli investitori istituzionali
10.6%
Jan 22, 2025 | PRESIDENT AND CEO | -52.42K | $11.20 | -$587.15K | SELL | -5.87% | 839.83K | Jan 17 | ||
Jan 22, 2025 | CHIEF FINANCIAL OFFICER | -20.15K | $11.20 | -$225.68K | SELL | -7.13% | 262.61K | Jan 17 | ||
Jan 22, 2025 | CHIEF BUSINESS OFFICER | -15.94K | $11.20 | -$178.50K | SELL | -6.60% | 225.54K | Jan 17 | ||
Jan 22, 2025 | CHIEF MEDICAL OFFICER | -18.48K | $11.20 | -$206.97K | SELL | -8.67% | 194.57K | Jan 17 | ||
Jan 22, 2025 | CHIEF HUMAN RESOURCE OFFICER | -3.74K | $11.20 | -$41.89K | SELL | -13.22% | 24.55K | Jan 17 | ||
Jan 22, 2025 | GENERAL COUNSEL & CORP. SEC'Y | -23.50K | $11.11 | -$261.10K | SELL | -24.99% | 70.54K | Jan 17 - Jan 22 | ||
Jul 12, 2024 | CHIEF MEDICAL OFFICER | -12.32K | $11.56 | -$142.41K | SELL | -5.47% | 213.05K | Jul 10 | ||
Jul 12, 2024 | CHIEF BUSINESS OFFICER | -9.90K | $11.56 | -$114.44K | SELL | -3.94% | 241.48K | Jul 10 | ||
Jul 12, 2024 | CHIEF FINANCIAL OFFICER | -10.91K | $11.56 | -$126.13K | SELL | -3.72% | 282.12K | Jul 10 | ||
Jul 12, 2024 | PRESIDENT AND CEO | -38.71K | $11.56 | -$447.49K | SELL | -4.16% | 892.25K | Jul 10 | ||
Jul 12, 2024 | GENERAL COUNSEL & CORP. SEC'Y | -7.66K | $11.56 | -$88.50K | SELL | -7.53% | 94.04K | Jul 10 | ||
Jan 19, 2024 | CHIEF FINANCIAL OFFICER | -9.78K | $17.23 | -$168.53K | SELL | -4.79% | 194.60K | Jan 17 | ||
Jan 19, 2024 | CHIEF BUSINESS OFFICER | -9.79K | $17.23 | -$168.61K | SELL | -4.69% | 199.05K | Jan 17 | ||
Jan 19, 2024 | PRESIDENT AND CEO | -25.72K | $17.23 | -$443.17K | SELL | -3.42% | 725.70K | Jan 17 | ||
Jan 19, 2024 | CHIEF MEDICAL OFFICER | -10.29K | $17.23 | -$177.38K | SELL | -6.16% | 156.92K | Jan 17 | ||
Jan 19, 2024 | GENERAL COUNSEL & CORP. SEC'Y | -5.20K | $17.23 | -$89.54K | SELL | -8.60% | 55.25K | Jan 17 | ||
Aug 07, 2023 | CHIEF BUSINESS OFFICER | -20.73K | $12.34 | -$604.55K | SELL | -9.03% | 208.84K | Aug 03 - Aug 04 | ||
Jul 21, 2023 | GENERAL COUNSEL & CORP. SEC'Y | -4.75K | $17.55 | -$83.45K | SELL | -7.29% | 60.44K | Jul 20 | ||
Jul 19, 2023 | GENERAL COUNSEL & CORP. SEC'Y | -12.78K | $18.01 | -$230.12K | SELL | -16.39% | 65.20K | Jul 17 | ||
Jul 19, 2023 | CHIEF MEDICAL OFFICER | -22.32K | $18.01 | -$401.98K | SELL | -11.78% | 167.22K | Jul 17 | ||
Jul 19, 2023 | CHIEF BUSINESS OFFICER | -17.94K | $18.01 | -$323.03K | SELL | -7.14% | 233.17K | Jul 17 | ||
Jul 19, 2023 | CHIEF FINANCIAL OFFICER | -19.77K | $18.01 | -$356.06K | SELL | -8.84% | 204.00K | Jul 17 | ||
Jul 19, 2023 | PRESIDENT AND CEO | -70.15K | $18.01 | -$1.26M | SELL | -8.54% | 751.42K | Jul 17 | ||
Apr 03, 2023 | GENERAL COUNSEL & CORP. SEC'Y | -7.75K | $26.62 | -$206.33K | SELL | -13.24% | 50.79K | Mar 30 - Apr 03 | ||
Apr 03, 2023 | CHIEF MEDICAL OFFICER | -11.24K | $26.52 | -$298.23K | SELL | -7.16% | 145.79K | Mar 30 | ||
Apr 03, 2023 | CHIEF BUSINESS OFFICER | -9.04K | $26.52 | -$239.64K | SELL | -4.02% | 215.95K | Mar 30 | ||
Apr 03, 2023 | CHIEF FINANCIAL OFFICER | -9.96K | $26.52 | -$264.15K | SELL | -6.29% | 148.47K | Mar 30 | ||
Apr 03, 2023 | PRESIDENT AND CEO | -35.34K | $26.52 | -$937.22K | SELL | -4.91% | 684.07K | Mar 30 | ||
Feb 06, 2023 | PRESIDENT AND CEO | 0.00 | $20.07 | -$830.83K | SELL-OPTIONS | 0.00% | 649.43K | Feb 02 - Feb 03 | ||
Feb 01, 2023 | PRESIDENT AND CEO | 0.00 | $19.18 | -$1.38M | SELL-OPTIONS | 0.00% | 649.43K | Jan 30 - Feb 01 | ||
Jan 27, 2023 | PRESIDENT AND CEO | 121.30K | $18.70 | -$1.88M | SELL-OPTIONS | 42.12% | 409.32K | Jan 25 - Jan 27 | ||
Jan 25, 2023 | PRESIDENT AND CEO | -15.00K | $17.60 | -$1.89M | SELL | -13.79% | 93.81K | Jan 23 - Jan 25 | ||
Jan 25, 2023 | GENERAL COUNSEL & CORP. SEC'Y | 0.00 | $26.14 | -$322.08K | SELL-OPTIONS | 0.00% | 5.95K | Jan 23 | ||
Jan 25, 2023 | CHIEF MEDICAL OFFICER | -67.50K | $34.48 | -$2.33M | SELL | -46.74% | 76.93K | Jan 23 | ||
Jan 25, 2023 | CHIEF FINANCIAL OFFICER | 0.00 | $19.75 | -$915.15K | SELL-OPTIONS | 0.00% | 84.42K | Jan 23 | ||
Jan 09, 2023 | PRESIDENT AND CEO | 0.00 | $10.58 | -$339.81K | SELL-OPTIONS | 0.00% | 543.13K | Jan 06 - Jan 09 | ||
Jan 05, 2023 | PRESIDENT AND CEO | 0.00 | $10.64 | -$513.49K | SELL-OPTIONS | 0.00% | 543.13K | Jan 03 - Jan 04 | ||
Dec 23, 2022 | GENERAL COUNSEL & CORP. SEC'Y | -2.93K | $19.38 | -$56.73K | SELL | -32.99% | 5.95K | Dec 22 | ||
Dec 21, 2022 | CHIEF FINANCIAL OFFICER | 9.73K | $19.10 | -$184.20K | GRANT | 13.77% | 80.42K | Dec 19 - Dec 20 | ||
Dec 21, 2022 | PRESIDENT AND CEO | 34.54K | $19.10 | -$653.53K | GRANT | 6.79% | 543.13K | Dec 19 - Dec 20 | ||
Dec 21, 2022 | CHIEF MEDICAL OFFICER | 10.99K | $19.10 | -$207.97K | GRANT | 8.24% | 144.43K | Dec 19 - Dec 20 | ||
Dec 21, 2022 | GENERAL COUNSEL & CORP. SEC'Y | 8.88K | $19.10 | -$90.14K | GRANT | ∞ | 8.88K | Dec 19 - Dec 20 | ||
Dec 21, 2022 | CHIEF BUSINESS OFFICER | 8.83K | $19.10 | -$167.11K | GRANT | 6.16% | 152.18K | Dec 19 - Dec 20 | ||
Oct 27, 2022 | CHIEF MEDICAL OFFICER | -5.00K | $25.05 | -$125.24K | SELL | -3.61% | 133.44K | Oct 25 | ||
Sep 14, 2022 | PRESIDENT AND CEO | 0.00 | $12.31 | -$255.85K | SELL-OPTIONS | 0.00% | 508.59K | Sep 12 | ||
Jul 13, 2022 | CHIEF MEDICAL OFFICER | -3.00K | $20.00 | -$60.00K | SELL | -2.12% | 138.44K | Jul 11 | ||
Jul 13, 2022 | PRESIDENT AND CEO | 0.00 | $12.29 | -$561.51K | SELL-OPTIONS | 0.00% | 508.59K | Jul 11 - Jul 12 | ||
Jun 22, 2021 | CHIEF MEDICAL OFFICER | -12.50K | $28.87 | -$360.82K | SELL | -8.36% | 137.08K | Jun 18 | ||
Jun 15, 2021 | PRESIDENT AND CEO | -4.00K | $33.03 | -$132.10K | SELL | -0.79% | 504.16K | Jun 14 | ||
May 17, 2021 | PRESIDENT AND CEO | -3.50K | $28.64 | -$100.22K | SELL | -0.68% | 508.16K | May 14 | ||
Apr 15, 2021 | PRESIDENT AND CEO | 2.50K | $16.21 | -$93.68K | SELL-OPTIONS | 0.55% | 456.82K | Apr 13 - Apr 14 | ||
Mar 19, 2021 | CHIEF MEDICAL OFFICER | -12.50K | $39.41 | -$492.68K | SELL | -7.71% | 149.58K | Mar 18 | ||
Mar 17, 2021 | PRESIDENT AND CEO | -3.50K | $38.52 | -$134.83K | SELL | -0.68% | 509.16K | Mar 15 | ||
Feb 17, 2021 | PRESIDENT AND CEO | -3.50K | $32.67 | -$114.35K | SELL | -0.68% | 512.66K | Feb 16 | ||
Jan 15, 2021 | PRESIDENT AND CEO | -3.50K | $26.38 | -$92.33K | SELL | -0.67% | 516.16K | Jan 14 | ||
Dec 21, 2020 | — | -12.50K | $26.54 | -$331.75K | SELL | -7.16% | 162.08K | Dec 18 | ||
Dec 16, 2020 | — | -3.50K | $27.37 | -$95.79K | SELL | -0.67% | 519.66K | Dec 14 | ||
Dec 02, 2020 | — | 0.00 | $16.83 | -$493.50K | OPTION EXERCISE | 0.00% | 23.12K | Dec 01 |
FAQ
L'insider trading è legale?
L'insider trading è legale a condizione che gli insider segnalino le loro operazioni alla SEC. Il trading illegale di titoli si verifica quando l'insider viola un dovere fiduciario o non segnala le sue operazioni.
Quali sono alcuni esempi di manipolazione del mercato?
L'insider trading, gli schemi di pump and dump, il front running e i wash trade sono tutti esempi di manipolazione del mercato. Gli investitori che seguono i movimenti delle attività degli insider dovrebbero riflettere attentamente sul motivo per cui questi insider stanno negoziando le loro azioni prima di procedere.
Sfoglia insider trading su tutte le azioni.